Gisborne Hospital Report - Health and Disability Commissioner
Gisborne Hospital Report - Health and Disability Commissioner
Gisborne Hospital Report - Health and Disability Commissioner
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Gisborne</strong> <strong>Hospital</strong> 1999 – 2000<br />
PSA Testing Procedures<br />
3.31 QC <strong>Report</strong>er 2.0 was a software package created by Westgard Inc applying<br />
mathematical/statistical rules for quality control. This Westgard Rules<br />
programme was used to determine if the quality control rules were able to<br />
detect clinically significant errors, which had been introduced into the system.<br />
This programme required data to be entered before it could produce a CV%<br />
st<strong>and</strong>ard deviation graphically represented, so that it could be detected if<br />
results were going “out of control” (outside the tolerable limits of st<strong>and</strong>ard<br />
deviation).<br />
3.32 The AxSYM <strong>and</strong> Beckman analysers had ‘on board’ quality control data<br />
management systems. However, according to Mr Rutledge, these quality<br />
control systems were not “easily managed in terms of data manipulation or<br />
data summary” <strong>and</strong> were more “labour intensive”. According to THL these<br />
‘on board’ quality control systems were not in use at the time.<br />
3.33 Mr Rutledge explained that it was his practice every month, using the QC<br />
<strong>Report</strong>er 2.0 programme, to print out the quality control graphs (Levey-<br />
Jennings plots) for that month, as well as a weekly summary for the last 12<br />
months. He could then see if over one week the results had shifted. If<br />
anything had happened he could make entries in the comments column of his<br />
spreadsheet to give an explanation for the observed variance.<br />
3.34 The QC <strong>Report</strong>er 2.0 programme required staff (usually Mr Rutledge) to take<br />
the quality control printouts off the analysers, <strong>and</strong> to sit down in the chemistry<br />
office <strong>and</strong> type in the data. The software would then assess the data against<br />
the Multirule tests <strong>and</strong> the programme would graphically represent the results<br />
as being within or outside the allowable range for that test. The programme<br />
produced a Levey-Jennings graph for each analyte. It showed what had<br />
happened over the month or weekly over a six-month period, averaging out<br />
results. Mr Rutledge thought this was superior to the analysis provided by the<br />
“on board” quality control data management systems.<br />
3.35 Mr Rutledge believed “that the QC <strong>Report</strong>er 2.0 programme allowed for easier<br />
calculations <strong>and</strong> produced good graph results to assist in analysis of the data”.<br />
He observed that “the QC <strong>Report</strong>er programme was used over a number of<br />
years <strong>and</strong> [was] never commented on adversely in any of the IANZ reports,<br />
nor were any CARs [Corrective Action Requests] raised with regard to it”.<br />
PSA testing<br />
3.36 Mr Rutledge stressed that he had not been asked for his perspective by THL<br />
during its investigation into the cause of the problem. He has attempted to<br />
determine a cause from media reports. Without access to the relevant data he<br />
was only able to surmise <strong>and</strong> speculate on what was found by the THL internal<br />
investigation. Nor was he able to say what may have happened since he left<br />
the laboratory in early March 2000. The PSA testing error was discovered in<br />
June 2000.<br />
3.37 Mr Rutledge said that he followed the manufacturer’s st<strong>and</strong>ard operating<br />
procedures in running biochemistry tests. He noted, “the fact is that we were<br />
not informed by Abbott Diagnostics that the [Total PSA] calibrators would<br />
147